Αποτελέσματα Αναζήτησης
6 Μαρ 2024 · A once-daily oral combination therapy for HIV — bictegravir plus lenacapavir — is more effective than complex regimens are, according to results from a phase 2 study of people with HIV who are virologically suppressed, presented the Conference on Retrovirus and Opportunistic Infections (CROI) in Denver.
- Top 5 stories on new drugs for HIV prevention and treatment ... - Aidsmap
At the Conference on Retroviruses and Opportunistic...
- Top 5 stories on new drugs for HIV prevention and treatment ... - Aidsmap
4 Ιαν 2023 · Sunlenca is the first of a new class of drugs called capsid inhibitors to be FDA-approved for treating HIV-1. Sunlenca works by blocking the HIV-1 virus’ protein shell (the capsid), thereby interfering with multiple essential steps of the viral lifecycle.
14 Μαρ 2023 · At the Conference on Retroviruses and Opportunistic Infections (CROI 2023) in February, many researchers presented studies looking at new drugs being tested for use as treatment, pre-exposure prophylaxis (PrEP), and post-exposure prophylaxis (PEP). Here are some highlights.
17 Απρ 2024 · New regimens in development, including once-weekly pills and semiannual shots, could help control the virus in hard-to-reach populations.
23 Δεκ 2021 · The Food and Drug Administration has approved the first injectable medication for HIV prevention. Health advocates say it could be a game changer in protecting people against AIDS
22 Αυγ 2023 · Descovy, approved to prevent H.I.V. in men and transgender women, is thought to be safer than Truvada. And cabotegravir, a bimonthly injection, is an alternative for people who are unable or...
30 Αυγ 2023 · How this new HIV drug therapy works. In essence, lenacapavir tackles the capsid, a conical structure that harbors the RNA (ribonucleic acid) of HIV and other proteins that HIV uses to enter and replicate in human cells.
